Cryobiopsy at the dawn of fibrosis: unlocking early diagnosis and therapeutic windows - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Cryobiopsy in Early Fibrosis: Enhancing Diagnosis and Treatment Opportunities

  • By

  • Claudia Carducci

  • Naftali Kaminski

  • Aurélien Justet

  • Sara Tomassetti

  • August 12, 2026

Share

  • 1

    Transbronchial lung cryobiopsy (TBLC) is a less invasive alternative to surgical lung biopsy for assessing interstitial lung diseases.

  • 2

    The role of TBLC in diagnosing interstitial lung abnormalities and early interstitial lung diseases is not yet clearly defined.

  • 3

    Standardized protocols for TBLC are lacking, affecting diagnostic performance and introducing variability across different centers.

  • 4

    Cryobiopsy specimens provide sufficient alveolated tissue to identify histopathological patterns not detectable with traditional biopsies.

  • 5

    There is a need for rigorously designed prospective studies to evaluate TBLC's potential in converting incidental findings into therapeutic opportunities.

Original Source(s)

Cryobiopsy at the dawn of fibrosis: unlocking early diagnosis and therapeutic windows

  • by Claudia Carducci, Naftali Kaminski, Aurélien Justet, Sara Tomassetti

  • August 12, 2026

Related Content

Construction and validation of a tracheostomy prediction model in mechanically ventilated stroke patients and the impact of early versus late tracheostomy on clinical outcomes: an IPTW-based analysis

FDA Monthly Preview: Key August Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Multitask learning for early treatment response and survival prediction in lung cancer radiotherapy using sequential CBCT imaging